Diabetes Management Journal SEPTEMBER 2017 digital edition

SCROLL DOWN FOR EDITION REFERENCES

Diabetes Management Journal is a clinical publication accessed via password. If you have not been provided a password by your professional association please send a request for the password to . with your full name and AHPRA number.

To read Diabetes Management Journal you will need adobe flash player installed. If you don't have the program you can download the official program here >

To read the publication easily click the enable full screen button above  Full screen icon    Prefer to read offline? Print the pages using this icon above  

If you are using Google Chrome and cannot see these icons in the toolbar please follow these instructions:

  1. In the address bar at the top of this page click Lock Lock or Info Information  directly to the left of the website address
  2. At the bottom of the dropdown, click Site Settings.
  3. In the new tab, to the right of "Flash," click Allow.
  4. Now come back to this page and reload. You should now see the Full Screen and Print buttons.
Diabetes Management Journal September 2017

Diabetes Management Journal September 2017 References

Page 5: Cancer Drug Imatinib May Slow New Onset Type 1 Diabetes

Louvet C, Szot G, Lang J et al. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci 2008;105. Reported by Busko M, Cancer Drug Imatinib May Slow New-Onset Type 1 Diabetes. Medscape 2017 June 26

Page 6: Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor

Fralick M, Schneeweiss S, Patorno E. Risk of Diabetic Ketoacidosis after initiation of an SGLT2 inhibitor. N Engl J Med 8 June 2017; 376: 2300-2302.
Isaacs M, Tonks K, Greenfield J. Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors. Internal Medicine Journal Jun 2017; 701-704

Page 6: The Impact of Hypos

Khunti K, Alsifri S, Aronson R et al. Impact of hypoglycaemia on patient-reported outcomes form a global, 24 country study of 27 585 people with type 1 and insulin treated type 2 diabetes. Diabetes Research and Clinical Practice. 2017 August, Vol 130, pgs 121-129.

Page 7: Researchers Call for Paradigm Shift in Type 2 Diabetes Treatment

Researchers Call for Paradigm Shift in Type 2 Diabetes Treatment. CWRUMed360 News Releases 2017 June 20.
Ismail-Beigi F, Moghissi, E, Kosiborod M, Inzucchi SE. Shifting Paradigms in the Medical Management of Type 2 Diabetes: Reflections on Recent Cardiovascular Outcome Trials. J Gen Intern Med 2017 May 26.

Page 7: Glycaemic control and weight loss with semaglutide in type 2 diabetes

Madsbad S, Holst J. Glycaemic control and weight loss with semaglutide in type 2 diabetes. The Lancet Diabetes and Endocrinology. May 2017, Vol 5; 315-317

Pages 8-13: Type 1 diabetes and the artificial pancreas

  1. Craig ME, Twigg SM, Donaghue KC, Cheung NW, Cameron FJ, Conn J, Jenkins AJ, Silink M, for the Australian Type 1 Diabetes Guidelines Expert Advisory Group. Draft national evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults, Australian Government Department of Health and Ageing, Canberra 2011.
  2. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994;331(21):1428-36.
  3. American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2015;38(Supplement 1):S8-S16.
  4. Karamitsos DT. The story of insulin discovery. Diabetes Res Clin Pract. 2011;93 Suppl 1:S2-8.
  5. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300(11):573-8.
  6. Australian Institute of Health and Welfare 2012. Insulin pump use in Australia. Diabetes series no.18. Cat. no. CVD 58. Canberra: AIHW.
  7. Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512.

Pages 14-17:   Diabetes and Emotional Health

  1. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clinical Diabetes. 2004;22(3):123-7.
  2. Speight J, Browne JL, et al. Diabetes MILES – Australia 2011 Survey Report. Diabetes Australia – Vic, Melbourne: 2011.
  3. Jones A, Vallis M, et al. If it does not significantly change HbA1c levels why should we waste time on it? A plea for the prioritization of psychological well-being in people with diabetes. Diabetic Medicine. 2015;32(2):155-63.
  4. Davies M, Dempster M, et al. Do people with diabetes who need to talk want to talk? Diabetic Medicine. 2006;23(8):917-19.
  5. Hendrieckx C, Bowden J, et al. An audit of psychological well-being in adults with type 1 diabetes. Paper presented at: Australian Diabetes Society and Australian Diabetes Educators Society Annual Scientific Meeting; 2012; Brisbane, Australia.
  6. Snoek FJ, Kersch NY, et al. Monitoring of Individual Needs in Diabetes (MIND): baseline data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care. 2011;34(3):601-3.
  7. Snoek FJ, Kersch NY, et al. Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care. 2012;35(11):2128-32.
  8. Malone A, Dempster M, et al. Providing psychological services for people with diabetes. Practical Diabetes International. 2005;22(7):244-8.
  9. Pouwer F, Beekman AT, et al. Nurses’ recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus. Patient Education and Counseling. 2006;60(2):235-40.
  10. Gonzalez JS, Fisher L, et al. Depression in diabetes: have we been missing something important? Diabetes Care. 2011;34(11):2488.
  11. Polonsky WH, Fisher L, et al. Assessing psychosocial distress in diabetes development of the Diabetes Distress Scale. Diabetes Care. 2005;28(3):626-31.
  12. Fisher L, Gonzalez JS, et al. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabetic Medicine. 2014;31(7):764-72.
  13. Polonsky WH. Diabetes burnout: what to do when you can't take it anymore. Virginia, USA: American Diabetes Association; 1999.
  14. Sturt J, Dennick K, et al. The detection and management of diabetes distress in people with type 1 diabetes. Current Diabetes Reports. 2015;15(11):1-14.
  15. Gonder-Frederick L. Fear of hypoglycemia: a review. Diabetic Hypoglycemia. 2013;5(3):3-11.
  16. Fear of hypoglycaemia is usually assessed with the Hypoglycaemia Fear Survey-II but there is not yet a clinically relevant cut-off point available. Data are based on mean +1SD (personal communication Linda Gonder-Frederick, 2015).
  17. Vallis M, Jones A, et al. Managing hypoglycaemia in diabetes may be more fear management than glucose management: a practical guide for diabetes care providers. Current Diabetes Reviews. 2014;10(6):364-70.
  18. Gherman A, Veresiu I, et al. Psychological insulin resistance: a critical review of the literature. Practical Diabetes International. 2011;28(3):125-8.
  19. Holmes-Truscott E, Skinner T, et al. Negative appraisals of insulin therapy are common among adults with type 2 diabetes using insulin: results from Diabetes MILES – Australia cross-sectional survey. Diabetic Medicine. 2015;32(10):1297-303.
  20. Larkin ME, Capasso VA, et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educator. 2008;34(3):511-7.
  21. Karter AJ, Subramanian U, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33(4):733-5.
  22. Blonde L. Easing the transition to insulin therapy in people with type 2 diabetes. Diabetes Educator. 2007;33(Suppl 7):S232-40.
  23. Funnell MM. Quality of life and insulin therapy in type 2 diabetes mellitus. Insulin. 2008;3(1):31-6.
  24. Makine C, Kar C, et al. Symptoms of depression and diabetes specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium. Diabetic Medicine. 2009;26(1):28-33.
  25. Lee CMY, Colagiuri R, et al. The cost of diabetes in adults in Australia. Diabetes Research and Clinical Practice. 2013;99(3): 385-90.
  26. Ho PM, Rumsfeld JS, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine. 2006;166(17):1836-41.
  27. Klein R, Klein BE. Relation of glycemic control to diabetic complications and health outcomes. Diabetes Care. 1998;21 (Suppl 3):C39-43.
  28. Donnelly LA, Morris AD, et al. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. Quarterly Journal of Medicine. 2007;100(6):345-50.
  29. Brod M, Kongso JH, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Quality of Life Research. 2009;18(1):23-32.
  30. Mezuk B, Eaton WW, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383-90.
  31. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. Journal of Affective Disorders. 2012;142:S8-21.
  32. Moulton CD, Pickup JC, et al. The link between depression and diabetes: the search for shared mechanisms. The Lancet Diabetes & Endocrinology. 2015;3(6):461-71.
  33. .
  34. Renn BN, Feliciano L, et al. The bidirectional relationship of depression and diabetes: a systematic review. Clinical Psychology +Review. 2011;31(8):1239-46.
  35. SANE Australia. Fact sheet 12: anxiety disorders, 2014 [cited 12 January 2015]. Available from: .
  36. Pinhas-Hamiel O, Levy-Shraga Y. Eating disorders in adolescents with type 2 and type 1 diabetes. Current Diabetes Reports. 2013;13(2):289-97.
  37. Young V, Eiser C, et al. Eating problems in adolescents with type 1 diabetes: a systematic review with meta-analysis. Diabetic Medicine. 2013;30(2):189-98.

Pages 20-21: Sarcopenia and Type 2 Diabetes

  1. National Diabetes Services Scheme report 31 March 2016 https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/69404736-9b16-4e67-87a0-57bfd6be9636.pdf
  2. Scott D, de Courten B & Ebeling PR. Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia’s ageing population! Med J Aust. 2016 Oct 3;205(7):329-333.
  3. Evans W. J. What is Sarcopenia. J Gerontol a-Biol 1995;50:5–8.
  4. Wang T, Feng , Zhou J et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep Sci Rep. 2016; 6: 38937.
  5. Cruz-Gentofte AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing. 2010;39:412–423.
  6. Kim KS, Park KS, Kim MJ, et al. Type 2 diabetes is associated with low muscle mass in older adults. Geriatr Gerontol Int 2014;14:115–21.
  7. Umegaki H. Sarcopenia and diabetes: hyperglycemia is a risk factor for age-associated muscle mass and functional reduction. J Diabetes Investig 2015 Nov;6(6):623-624.
  8. Phillips SM, Chevalier S &Leidy HJ. Protein “requirements” beyond the RDA: implications for optimizing health. Appl Physiol Nutr Metab 2016; 41: 565-572.
  9. Miljkovic I, Kulpers Al, Cauley JA et al. Greater skeletal muscle fat infiltration is associated with higher all-cause and cardiovascular mortality in older men. J Gerontol A Biol Sci Med Sci 2015;70:1133-1140.
  10. Breen L & Phillips S. Skeletal muscle protein metabolism in the elderly: interventions to counteract the ‘anabolic resistance’ of ageing. Nutrition & Metabolism 2011;8:68.
  11. Food and Agriculture Organisation of the United Nations. Amino Acid Content of Foods and Biological Data on Proteins. Nutritional Study 24. Rome, Italy; 1981. http://www.fao.org/docrep/005/AC854T/AC854T68.htm#chII.7 Accessed July 20, 2017
  12. Rondanelli M, Klersy C, Terracol G, et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr 2016;103:830-840.

Pages 22-26: Incorporating a Diabetes Educator into a GP practice

  1. https://www.adea.com.au/credentialling/credentialled-diabeteseducators/
  2. https://www.adea.com.au/about-us/our-people/nurse-practitioner-cdes
  3. https://www.humanservices.gov.au/health-professionals/services/medicare/practice-incentives-program
  4. http://www.health.gov.au/internet/main/publishing.nsf/Content/health-mbsprimarycareitems-ahgs-diabetes-factsheet
  5. https://www.adea.com.au/credentialling/credentialled-diabetes-educators/private-health-insurance/
  6. https://www.adea.com.au/

Page 32-34: Plant-based diets for weight loss

  1. Dinu M, Abbate R, Gensini GF, Casini A, Sofi F. Vegetarian, vegan diets and multiple health outcomes: A systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr. 2017;57(17):3640-3649. doi:10.1080/10408398.2016.1138447.
  2. Tonstad S, Butler T, Yan R, Fraser GE. Type of vegetarian diet, body weight, and prevalence of type 2 diabetes. Diabetes Care. 2009;32(5):791-6. Epub 2009 Apr 7.
  3. Appleby PN, Crowe FL, Bradbury KE, Travis RC, Key TJ. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom. Am J Clin Nutr. 2016;103(1):218-230. doi:10.3945/ajcn.115.119461.
  4. Rosell M, Appleby P, Spencer E, Key T. Weight gain over 5 years in 21,966 meat-eating, fish-eating, vegetarian, and vegan men and women in EPIC-Oxford. Int J Obes (Lond). 2006;30(9):1389-96. Epub 2006 Mar 14.
  5. Barnard ND, Levin SM, Yokoyama Y. A Systematic Review and Meta-Analysis of Changes in Body Weight in Clinical Trials of Vegetarian Diets. J Acad Nutr Diet. 2015;115(6):954-969. doi:10.1016/j.jand.2014.11.016.
  6. Eichelmann F, Schwingshackl L, Fedirko V, Aleksandrova K. Effect of plant-based diets on obesity-related inflammatory profiles: a systematic review and meta-analysis of intervention trials. Obes Rev. 2016;17(11):1067-1079. doi:10.1111/obr.12439.
  7. Turner-McGrievy GM, Davidson CR, Wingard EE, Wilcox S, Frongillo EA. Comparative effectiveness of plant-based diets for weight loss: A randomized controlled trial of five different diets. Nutrition. doi:10.1016/j.nut.2014.09.002.
  8. Barnard ND, Cohen J, Jenkins DJ, et al. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006;29(8):1777-1783.
  9. Barnard ND, Cohen J, Jenkins DJ, et al. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr. 2009;89(5):1588S-1596S. Epub 2009 Apr 1.
  10. Kahleova H, Matoulek M, Malinska H, et al. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabet Med. 2011;28(5):549-59. doi: 10.1111/j.1464-5491.2010.03209.x.
  11. Slavin JL, McBurney MI, Slavin JL, et al. Dietary fiber and body weight. Nutrition. 2005;21(3):411-418. doi:10.1016/j.nut.2004.08.018.
  12. Pérez-Escamilla R, Obbagy JE, Altman JM, et al. Dietary energy density and body weight in adults and children: a systematic review. J Acad Nutr Diet. 2012;112(5):671-684. doi:10.1016/j.jand.2012.01.020.
  13. 13. Wang Y, Beydoun MA. Meat consumption is associated with obesity and central obesity among US adults. Int J Obes. 2009;33(6):621-628. http://dx.doi.org/10.1038/ijo.2009.45.
  14. 14. Vergnaud AC, Norat T, Romaguera D, et al. Meat consumption and prospective weight change in participants of the EPIC-PANACEA study. Am. 92(2):398-407. Epub 2010 Jun 30.
  15. 15. Romaguera D, Norat T, Vergnaud AC, et al. Mediterranean dietary patterns and prospective weight change in participants of the EPIC-PANACEA project. Am. 92(4):912-21. Epub 2010 Sep 1.
  16. 16. Schulz M, Kroke A, Liese AD, Hoffmann K, Bergmann MM, Boeing H. Food groups as predictors for short-term weight changes in men and women of the EPIC-Potsdam cohort. J Nutr. 2002;132(6):1335-40.
  17. 17. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392-404. doi: 10.1056/NEJMoa1014296.
  18. 18. Barnard ND, Scialli AR, Turner-McGrievy G, Lanou AJ. Acceptability of a low-fat vegan diet compares favorably to a step II diet in a randomized, controlled trial. J Cardiopulm Rehabil. 2004;24(4):229-35.
  19. 19. Barnard ND, Gloede L, Cohen J, et al. A low-fat vegan diet elicits greater macronutrient changes, but is comparable in adherence and acceptability, compared with a more conventional diabetes diet among individuals with type 2 diabetes. J Am Diet Assoc. 2009;109(2):263-72.
  20. 20. Turner-McGrievy GM, Davidson CR, Wingard EE, Wilcox S, Frongillo EA. Comparative effectiveness of plant-based diets for weight loss: A randomized controlled trial of five different diets. Nutrition. 2015;31(2):350-358. doi:10.1016/j.nut.2014.09.002.
  21. 21. Roy Morgan Single Source (Australia), April 2011-March 2012 (n=19,167); April 2015-March 2016 (n=14,380) http://www.roymorgan.com/findings/vegetarianisms-slow-but-steady-rise-in-australia-20160815110521.    
  22. 22. Melina V, Craig W, Levin S. Position of the Academy of Nutrition and Dietetics: Vegetarian Diets. J Acad Nutr Diet. 2016;116(12):1970-1980. doi:10.1016/j.jand.2016.09.025.
  23. 23. Reid MA, Marsh KA, Zeuschner CL, Saunders A V, Baines SK. Meeting the nutrient reference values on a vegetarian diet. Med J Aust. 2013;199(4 Suppl):S33-40. www.mja.com.au/journal/2013/199/4/meeting-nutrient-reference-values-vegetarian-diet.